Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/34441
Title: Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma
Authors: Rodini, Carolina Oliveira [UNIFESP]
Suzuki, Daniela Emi [UNIFESP]
Saba-Silva, Najsla [UNIFESP]
Cappellano, Andrea [UNIFESP]
Souza, Jorge Estefano Santana de
Cavalheiro, Sergio [UNIFESP]
Toledo, Silvia Regina Caminada de [UNIFESP]
Okamoto, Oswaldo Keith
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Hosp Alema Oswaldo Cruz
Keywords: Medulloblastoma
CD133
LIN28
OCT4
Prognosis
Stem cell markers
Issue Date: 1-Jan-2012
Publisher: Springer
Citation: Journal of Neuro-oncology. New York: Springer, v. 106, n. 1, p. 71-79, 2012.
Abstract: Aberrant expression of stem cell-related genes in tumors may confer more primitive and aggressive traits affecting clinical outcome. Here, we investigated expression and prognostic value of the neural stem cell marker CD133, as well as of the pluripotency genes LIN28 and OCT4 in 37 samples of pediatric medulloblastoma, the most common and challenging type of embryonal tumor. While most medulloblastoma samples expressed CD133 and LIN28, OCT4 expression was found to be more sporadic, with detectable levels occurring in 48% of tumors. Expression levels of OCT4, but not CD133 or LIN28, were significantly correlated with shorter survival (P <= 0.0001). Median survival time of patients with tumors hyperexpressing OCT4 and tumors displaying low/undetectable OCT4 expression were 6 and 153 months, respectively. More importantly, when patients were clinically stratified according to their risk of tumor recurrence, positive OCT4 expression in primary tumor specimens could discriminate patients classified as average risk but which further deceased within 5 years of diagnosis (median survival time of 28 months), a poor clinical outcome typical of high risk patients. Our findings reveal a previously unknown prognostic value for OCT4 expression status in medulloblastoma, which might be used as a further indicator of poor survival and aid postoperative treatment selection, with a particular potential benefit for clinically average risk patients.
URI: http://repositorio.unifesp.br/handle/11600/34441
ISSN: 0167-594X
Other Identifiers: http://dx.doi.org/10.1007/s11060-011-0647-9
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.